InsidersTradesSigma
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
16
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Elie FRAENCKEL, Director. Insider active across 1 company, notably BIOSYNEX. Cumulatively, 19 filings have been recorded. Breakdown: 16 buys · 2 sells. Total volume traded: €464k. History available since 19 April 2021. The latest transaction was filed on 14 February 2025 (Souscription). Regulator: AMF. The full history is free.
Companies and markets linked to Elie FRAENCKEL
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
13,832 shares@ €1.0095.8% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020943
10,975 shares@ €0.0453.4% of flowDPSEuronext Growth ParisISIN FR001400WOK32025DD1018760
1,000 shares@ €0.11720.8% of flowDPSEuronext Growth ParisISIN FR00110059332025DD1017643
2,500 shares@ €12.20196.6% of flowActionEuronext Growth ParisISIN FR00110059332023DD884526
Canonical exit: 11 May 2023 (T+90)
2,500 shares@ €12.27016.6% of flowActionEuronext Growth ParisISIN FR00110059332023DD884527
Canonical exit: 14 May 2023 (T+90)
1,000 shares@ €17.47093.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822689
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ €17.64543.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822659
Canonical exit: 23 May 2022 (T+90)
65 shares@ €17.400.2% of flowActionEuronext Growth ParisISIN FR00110059332022DD822669
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ €17.41893.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822648
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ €17.37353.7% of flowActionEuronext Growth ParisISIN FR00110059332022DD822649
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ €17.41663.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822654
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ €16.74623.6% of flowActionEuronext Growth ParisISIN FR00110059332022DD820969
Canonical exit: 11 May 2022 (T+90)
1,000 shares@ €16.783.6% of flowActionEuronext Growth ParisISIN FR00110059332022DD820965
Canonical exit: 11 May 2022 (T+90)
1,000 shares@ €16.74673.6% of flowActionEuronext Growth ParisISIN FR00110059332022DD820968
Canonical exit: 11 May 2022 (T+90)
1,000 shares@ €18.92324.1% of flowActionEuronext Growth ParisISIN FR00110059332021DD811810
Canonical exit: 8 Mar 2022 (T+90)
2,000 shares@ €24.0010.4% of flowActionEuronext Growth ParisISIN FR00110059332021DD758770
Canonical exit: 1 Sept 2021 (T+90)
2,000 shares@ €24.237810.5% of flowActionEuronext Growth ParisISIN FR00110059332021DD746002
Canonical exit: 22 Jul 2021 (T+90)
2,000 shares@ €24.1010.4% of flowActionEuronext Growth ParisISIN FR00110059332021DD742598
Canonical exit: 22 Jul 2021 (T+90)
4,000 shares@ €24.987921.6% of flowActionEuronext Growth ParisISIN FR00110059332021DD742006
Canonical exit: 18 Jul 2021 (T+90)
19 of 19 declarations
About Elie FRAENCKEL
Elie FRAENCKEL is Administrateur at BIOSYNEX (XPAR). He has 19 filings in total, and across the 19 most recent filings available, purchases total 477292 EUR and sales total 611 EUR, over the period from 2021-12-08 to 2025-02-18. The modal transaction nature is Acquisition.
